Miltenyi Biotec-tested panel 20 (MBTP 20)
This application protocol describes the flow cytometric analysis of the activation status of NK cells isolated from PBMCs from whole blood of a healthy donor. Immunophenotyping of NK cells was performed on all PBMCs, directly after isolation via CD3 depletion and CD56 enrichment, and after 14 days of culture.
|Channel||Specificity||Clone||Purpose||Fluorochrome||Detection filter (nm) (laser)|
|V1||CD56||REA196||NK cells||Vio® Bright V423||450/50 (violet)|
|B1||CD335 (NKp46)||REA808||Activation marker||Vio Bright B515||525/50 (blue)|
|B2||CD336 (NKp44)||REA1163||Activation marker||PE||585/40 (blue)|
|B3||7-AAD Staining Solution||-||Viability||-||655–730 (blue)|
|B3||CD3||REA613||Cell type exclusion||PerCP-Vio 700||655–730 (blue)|
|CD14||REA599||Cell type exclusion|
|B4||CD337 (NKp30)||REA823||Activation marker||PE-Vio 770||750LP (blue)|
|R1||CD314 (NKG2D)||REA797||Activation marker||APC||655–730 (red)|
|R2||CD16||REA423||Maturation marker||APC-Vio 770||750LP (red)|
Unless otherwise specifically indicated, Miltenyi Biotec products and services are for research use only and not for therapeutic or diagnostic use.
If not otherwise specified, all marks displayed on the Miltenyi Biotec Internet site and documents are subject to the trademark rights of Miltenyi Biotec, including each of Miltenyi Biotec's primary brands, its model name plates, and its corporate logos and emblems.
For copyright note and a complete list of trademarks visit www.miltenyibiotec.com/legalnotes.